FDA allows Philip Morris to market Zyn as less harmful than cigarettes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St falls as Big Tech earnings rekindle AI spending worries; oil hits $100
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
- Dollar hits fresh 40-year high versus yen, edges higher against euro
BofA on Philip Morris (PM): 'one of the best positioned companies in the consumer staples sector'
June 30, 2026 1:09 PM EDTBofA Securities analyst Lisa Lewandowski reiterated a Buy rating and $209.00 price target on Philip Morris (NYSE: PM).
The analyst comments "MRTP orders are important because the applications undergo strict, science-based testing for any tobacco product that claims to be less harmful than others. Before a manufacturer can market a product with reduced-risk or reduced-exposure claims, it must obtain an... More
